Survival with low- and high-flux dialysis.
chronic haemodialysis
dialysis
dialysis membranes
mortality
mortality risk
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
19
08
2020
accepted:
02
10
2020
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
5
8
2021
Statut:
epublish
Résumé
Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis was to survey, in HD patients, the relationship between the use of conventional low- or high-flux membranes and all-cause and cardiovascular mortality. COSMOS is a multicentre, open-cohort, 3-year prospective study, designed to evaluate mineral and bone disorders in the European HD population. The present analysis included 5138 HD patients from 20 European countries, 3502 randomly selected at baseline (68.2%), plus 1636 new patients with <1 year on HD (31.8%) recruited to replace patients who died, were transplanted, switched to peritoneal dialysis or lost to follow-up by other reasons. Cox-regression analysis with time-dependent variables, propensity score matching and the use of an instrumental variable (facility-level analysis) were used. After adjustments using three different multivariate models, patients treated with high-flux membranes showed a lower all-cause and cardiovascular mortality risks {hazard ratio (HR) = 0.76 [95% confidence interval (CI) 0.61-0.96] and HR = 0.61 (95% CI 0.42-0.87), respectively}, that remained significant after matching by propensity score for all-cause mortality (HR = 0.69, 95% CI 0.52-0.93). However, a facility-level analysis showed no association between the case-mix-adjusted facility percentage of patients dialysed with high-flux membranes and all-cause and cardiovascular mortality. High-flux dialysis was associated with a lower relative risk of all-cause and cardiovascular mortality. However, dialysis facilities using these dialysis membranes to a greater extent did not show better survival.
Sections du résumé
BACKGROUND
BACKGROUND
Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis was to survey, in HD patients, the relationship between the use of conventional low- or high-flux membranes and all-cause and cardiovascular mortality.
METHODS
METHODS
COSMOS is a multicentre, open-cohort, 3-year prospective study, designed to evaluate mineral and bone disorders in the European HD population. The present analysis included 5138 HD patients from 20 European countries, 3502 randomly selected at baseline (68.2%), plus 1636 new patients with <1 year on HD (31.8%) recruited to replace patients who died, were transplanted, switched to peritoneal dialysis or lost to follow-up by other reasons. Cox-regression analysis with time-dependent variables, propensity score matching and the use of an instrumental variable (facility-level analysis) were used.
RESULTS
RESULTS
After adjustments using three different multivariate models, patients treated with high-flux membranes showed a lower all-cause and cardiovascular mortality risks {hazard ratio (HR) = 0.76 [95% confidence interval (CI) 0.61-0.96] and HR = 0.61 (95% CI 0.42-0.87), respectively}, that remained significant after matching by propensity score for all-cause mortality (HR = 0.69, 95% CI 0.52-0.93). However, a facility-level analysis showed no association between the case-mix-adjusted facility percentage of patients dialysed with high-flux membranes and all-cause and cardiovascular mortality.
CONCLUSIONS
CONCLUSIONS
High-flux dialysis was associated with a lower relative risk of all-cause and cardiovascular mortality. However, dialysis facilities using these dialysis membranes to a greater extent did not show better survival.
Identifiants
pubmed: 34345415
doi: 10.1093/ckj/sfaa233
pii: sfaa233
pmc: PMC8323142
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1915-1923Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Références
N Engl J Med. 2002 Dec 19;347(25):2010-9
pubmed: 12490682
Nephrol Dial Transplant. 2019 Apr 1;34(4):673-681
pubmed: 29741651
Am J Nephrol. 2014;39(5):383-91
pubmed: 24776927
Contrib Nephrol. 2017;191:8-17
pubmed: 28910787
Kidney Int. 2013 Nov;84(5):998-1008
pubmed: 23823605
Kidney Int. 1991 May;39(5):1012-9
pubmed: 2067196
J Nephrol. 2017 Dec;30(6):795-801
pubmed: 28840494
J Am Soc Nephrol. 2009 Mar;20(3):645-54
pubmed: 19092122
Am J Kidney Dis. 2012 Jul;60(1):90-101
pubmed: 22385781
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005016
pubmed: 22972082
J Am Soc Nephrol. 2013 May;24(6):1014-23
pubmed: 23620396
Nephrol Dial Transplant. 2008 Jul;23(7):2337-43
pubmed: 18305316
Clin J Am Soc Nephrol. 2008 Jan;3(1):69-77
pubmed: 18057309
Nephrol Dial Transplant. 2013 Jul;28(7):1694-9
pubmed: 22833620
Am J Kidney Dis. 2007 Feb;49(2):267-75
pubmed: 17261429
J Am Soc Nephrol. 2006 Feb;17(2):546-55
pubmed: 16382021
Kidney Int. 2006 Jun;69(11):2087-93
pubmed: 16641921
Kidney Int. 2004 Jun;65(6):2380-9
pubmed: 15149351
Am J Nephrol. 1996;16(6):484-8
pubmed: 8955759
Am J Kidney Dis. 2005 Mar;45(3):565-71
pubmed: 15754279
Nephrol Dial Transplant. 2018 Apr 1;33(4):683-689
pubmed: 29040687
J Nephrol. 2008 May-Jun;21(3):290-8
pubmed: 18587716
Artif Organs. 2003 Mar;27(3):218-23
pubmed: 12662205
PLoS One. 2014 Jun 06;9(6):e97184
pubmed: 24906205
Lancet. 2016 Jul 16;388(10041):294-306
pubmed: 27226132
Am J Kidney Dis. 2017 Feb;69(2):266-277
pubmed: 27866964
J Am Soc Nephrol. 2003 Dec;14(12):3251-63
pubmed: 14638924
Clin J Am Soc Nephrol. 2011 Jan;6(1):175-83
pubmed: 20947790
Am J Kidney Dis. 2001 Feb;37(2):276-86
pubmed: 11157367
Nephrol Dial Transplant. 2009 Mar;24(3):963-72
pubmed: 19028748
J Am Soc Nephrol. 2005 Jan;16(1):237-46
pubmed: 15563561
Nephrol Dial Transplant. 2015 Sep;30(9):1542-51
pubmed: 25920921
Am J Kidney Dis. 2006 Jan;47(1):131-8
pubmed: 16377394
Nephrol Dial Transplant. 2009 Dec;24(12):3557-66
pubmed: 19820003
Am J Kidney Dis. 1999 Feb;33(2):349-55
pubmed: 10023649
Nephrol Dial Transplant. 2013 Jul;28(7):1922-35
pubmed: 23166310